Drugs / Donor Hematopoietic Stem Cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00619528 | Jan 2008 → Jul 2022 | immunodeficiency disease, transplant rejection | Northwestern University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Donor Hematopoietic Stem Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00619528 ↗ |
| Modality | Cell therapy | “purified donor hematopoietic Cluster of Differentiation (CD)34+ stem cells (DHSC)” NCT00619528 ↗ |